Literature DB >> 4863186

Gynecomastia associated with vincristine therapy.

R H Smith, O Barrett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4863186      PMCID: PMC1502785     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


× No keyword cloud information.
  6 in total

Review 1.  GYNECOMASTIA.

Authors:  D M LEVY; J B ERICH; A B HAYLES
Journal:  Postgrad Med       Date:  1964-09       Impact factor: 3.840

Review 2.  THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.

Authors:  I S JOHNSON; J G ARMSTRONG; M GORMAN; J P BURNETT
Journal:  Cancer Res       Date:  1963-09       Impact factor: 12.701

3.  Vincristine in the treatment of lymphomas and leukemias.

Authors:  R A BOHANNON; D G MILLER; H D DIAMOND
Journal:  Cancer Res       Date:  1963-05       Impact factor: 12.701

4.  Benign enlargement of the male breast.

Authors:  C J DEXTER
Journal:  N Engl J Med       Date:  1956-05-24       Impact factor: 91.245

5.  Gynecomastia; a review and an analysis of 160 cases.

Authors:  C E WHEELER; E P CAWLEY; H T GRAY; A C CURTIS
Journal:  Ann Intern Med       Date:  1954-05       Impact factor: 25.391

6.  Gynecomastia in adolescent boys.

Authors:  M NYDICK; J BUSTOS; J H DALE; R W RAWSON
Journal:  JAMA       Date:  1961-11-04       Impact factor: 56.272

  6 in total
  4 in total

1.  Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung.

Authors:  D Fairlamb; E Boesen
Journal:  Postgrad Med J       Date:  1977-05       Impact factor: 2.401

2.  Gynaecomastia associated with cimetidine.

Authors:  R W Spence; L R Celestin
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

Review 3.  Gynecomastia and drugs: a critical evaluation of the literature.

Authors:  Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal:  Eur J Clin Pharmacol       Date:  2015-04-02       Impact factor: 2.953

4.  Gynaecomastia complicating the treatment of myeloma.

Authors:  D M Large; J M Jones; S M Shalet; J H Scarffe; A C Gibbs
Journal:  Br J Cancer       Date:  1983-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.